Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
, Ltd and
Nitto Denko was the world's first transdermal patch for treatment of asthma. The
adhesive layer of the tape contains tulobuterol, a drug that dilates the bronchial
tubes making it easier for asthma sufferers to breathe. When the patch is applied
to the skin, the drug penetrates the skin and is absorbed into the blood stream
through the capillaries to flow throughout the body. This is in effect the same as
using an injection, but without requiring the use of a needle.
Unlike conventional oral and inhaled formulations, Hokunalin Tape has the Hokunalin
advantage of being able to appropriately control the concentration of the drug in Tape
the body. This means that users can control asthma attacks, which frequently
occur in the early morning, and that the burden on caregivers is also greatly
reduced.
The development of these patches, however, took 11 years and was full of
challenges.
Chapter 3: Tenacity was required to Solve the Problem of Drug Content and
Concentration Control
In order to achieve goals it is necessary to think a lot and then to translate the ideas that come
into action, and to repeat this process time and time again. Basically, manufacturing is a process
that requires you to get your hands dirty and involves much sweat and tears. There is nothing
glamorous about it at all. That is probably one of the reasons that success, when it eventually
comes, is particularly sweet.
At times it may seem as though you are facing a brick wall, but when you get off course you just
have to take the initiative and try something else. Nothing gets solved sitting at a desk.
World-first products do not suddenly appear as a result of some revolutionary idea. The
development of Hokunalin Tape teaches us much about the importance of continually trying
out various ideas and combinations.